Under new leadership, IDRx has raised $120 million to push its targeted treatment for a rare digestive tract cancer through early-stage studies.
The company plans …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University
Cardiff University researchers are examining how the use of WhatsApp can engage black men in Butetown and Grangetown with prostate cancer risk information and increase